Search

everythinglearnresearchcommunity

for

Search:↓

Higher CRHR1 levels in AA patients lead to increased inflammation.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Reporter characteristics affect detection of hair loss from cancer therapy.

People with hidradenitis suppurativa have a higher risk of heart attacks and strokes.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

The "exposure–crossover design" helps assess individual changes in risk after events like car crashes.

Blacks and Hispanics have higher chances of alopecia areata than Whites.

Alopecia areata is more common in Black and Hispanic people but less diagnosed in those with lower socioeconomic status.

People with androgenetic alopecia have a higher risk of heart disease.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

AI improves accuracy and consistency in diagnosing male pattern hair loss.

Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.

Higher doses of 5α-reductase inhibitors reduce mortality risk, while lower doses increase suicide risk.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

A new method effectively predicts estrogen-related health effects for early screening.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Lower 2D:4D finger ratios in HS patients suggest prenatal hormone influence on the disease.

Alopecia areata may increase the risk of cardiovascular disease.

People with alopecia areata may have a higher risk of thyroid diseases.

Females have a higher lifetime risk of alopecia areata than males.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.